Publications & Resources
El-Maouche D, Xu X, Cofrancesco J, Dobs AS, Brown TT. Prevalence of low bone mineral density in a low-income inner city population. J Bone and Miner Res 2011; 26(2):388-96. PMID: 20721937
Falcone EL, Mangili A, Skinner S, Alam A, Polak JH, Wanke CA. Framingham risk score and early markers of atherosclerosis in a cohort of adults infected with HIV. Antiviral Therapy 2011; 16:1-8. PMID: 21311103
Flanigan T, Zaller N, Beckwith CG, et al. Testing for HIV, Sexually Transmitted Infections, and Viral Hepatitis in Jails: Still a Missed Opportunity for Public Health and Prevention. JAIDS. 55: Suppl 2:S78-83.
Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis, 2011; 214:468-73.
Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL. Changes in blood borne infection risk among injection drug users. J Infect Dis 2011;203:587-94.
Sheehan HB, Benetucci J, Muzzio E, Redini L, Naveira J, Segura M, Weissenbacher M, Tang AM. High rates of selenium deficiency among HIV and HCV-infected and non-infected drug users in Buenos Aires, Argentina. Public Health Nutrition, 2011 (in press).
Smit E, Winters-Stone K, Tang AM, Crespo CJ. Frailty, dietary intake, and food insufficiency in older adults. 3rd North American Congress of Epidemiology, June 21-24, 2011, Montreal, Quebec, Canada.
Tang AM, Sheehan H, Jordan M, Duong DV, Terrin N, Dong K, Lien T, Trung NV, Wanke CA, Hien ND. Predictors of weight change in male HIV-positive injection drug users initiating antiretroviral therapy in Hanoi, Vietnam. AIDS Research and Treatment, 2011 (Epub ahead of print).
Tang AM, Bhatnagar T, Ramachandran R, Dong KR, Skinner S, Kumar MS, Wanke CA. Malnutrition in a population of HIV-positive and HIV-negative drug users living in Chennai, South India. Drug Alcohol Depend, 2011 March 18. PMID: 21420798, PMCID: in process
Taylor LE, Holubar M, Wu K, Bosch RJ, Wyles DL, Davis JA, Mayer KH, Sherman KE, Tashima KT. Incident Hepatitis C Virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis. 2011; doi: 10.1093/cid/ciq201. PMID: 21282184
Taylor LE, DeLong AK, Maynard M, Chapman S, Gholam PM, Blackard J, Rich JD, Mayer KH. Acute Hepatitis C Virus in a HIV-clinic: A screening strategy, risk factors and perception of risk. Accepted for publication in AIDS Patient Care and STDs (pending revisions).
Beckwith CG, Liu T, Bazerman LB, DeLong AK, Desjardins SF, Poshkus M, Flanigan TP. HIV risk behavior pre- and post-HIV testing in jail: A pilot study. JAIDS 2010; 53(4):485-90. NIHMSID: 172917.
Davie, LA and Mahaniah K. Office-based buprenorphine-naloxone opiod addiction treatment in a community health center serving a low-income Latino community. 41st American Society of Addiction Medicine Conference. April 16, 2010, San Francisco, CA.
Delaney Jac, Scherzer R, Biggs ML, Polak JF, Currier JS, O'Leary D, Tien P, Wanke CA, Kronmal RA, Bacchetti P, Grunfeld C. Associations between anti-retroviral drug use and HIV-specific risk factors with carotid intima-media thickness: The study of fat redistribution and metabolic change in HIV infection (FRAM). 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 19-22, 2010, Brighton, UK.
Garg S, Taylor LE, Grasso C, Mayer KH. Hepatitis C Seropositivity Among HIV-Infected Men who Have Sex with Men in Boston, MA. (Poster Presentation 736). 48th Annual Meeting of the Infectious Diseases Society of America (IDSA), Vancouver, British Columbia, Canada, October 21-24, 2010.
Jordan MR, Sheehan H, Hien ND, Lien TTM, Terrin N, Trung NV, Ha NTB, Duong DV, Wanke CA, Kinh NV, Tang AM. Correlates of adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam. (Oral presentation) 18th Annual International AIDS Conference, Vienna, Austria, July 18-23, 2010.
Jordan MR, Kearney M, Palmer S, Shao W, Maldarelli F, Coakley EP, Chappey C, Wanke CA, Coffin JM. Comparison of standard PCR/Cloning to single genome sequencing for analysis of HIV-1 populations. J of Virological Methods, 2010; 168: 114-20.
Kacanek D, Jacobson DL, Spiegelman D, Wanke CA, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: A longitudinal analysis from the Nutrition for Healthy Living Study. JAIDS 2010; 53(2):266-72. PMID: 20104122
Mangili A, Polak JF, Gerrior J, Tang A, Wanke C. Metabolic and cardiac risk factors in HIV-infected drug users. 41st American Society of Addiction Medicine Conference. April 16, 2010, San Francisco, CA.
McMahon J, Tang AM, Skinner S, Elliott J, Rubin A, Sprague S, Wanke CA. Associations between food security, body mass index, and immunological response. 18th Annual International AIDS Conference, Vienna, Austria, July 18-23, 2010.
McMahon J, Wanke C, Terrin N, Skinner S, Knox T. Poverty, hunger, education and residential status impact survival in HIV. AIDS Behavior, July 15, 2010 . PMID: 20632079
Rana A, Gillani FS, Flanigan TP, Nash BT, Beckwith CG. Follow-up care among HIV-infected pregnant women in Mississippi. J Womens Health (Larchmt) 2010; 19(10):1863-7.
Rich JD and Taylor LE. The Beginning of a New Era in Understanding Hepatitis C Virus Prevention. J Infect Dis. 2010; 202(7):981–983.
Supabhorn P, Ananworanich J, Forrester JE, Teeratakulpisarn N, Jadwattanakul T, Chomechey N, Sangphoe U, Wanke C, Phanuphak P, and Phanuphak N. Validation of Anthropometry and BIA against DEXA for Body Composition Assessment in Antiretroviral-naïve HIV-infected Thai Patients. 17th Conference on Retroviruses and Opportunistic Infections (CROI), February 16-19, 2010.
Tang AM, Forrester JA, Spiegelman D, Flanigan T, Dobs A, Skinner S, Wanke C. Heavy injection drug use is associated with lower percent body fat in a multi-ethnic cohort of HIV-positive and HIV-negative drug users from three U.S. cities. Am J Drug Alcohol Abuse 2010; 36(1):78-86. PMCID#178466.
Tang AM, Jordan M, Lien TTM, Duong DV, Sheehan H, Terrin N, Trung NV, Ha NTB, Kinh NV, Wanke CA, Hien ND. Predictors of weight gain in a cohort of HIV-positive injection drug users (IDUs) initiating antiretroviral (ARV) therapy in Hanoi, Vietnam. 18th Annual International AIDS Conference, Vienna, Austria, July 18-23, 2010.
Tang AM, Bhatnagar T, Ramachandran R, Kumar MS, Dong KR, Skinner S, Krishnan K, Bolton PA, Wanke CA. Food insecurity and symptoms of depression in a cohort of HIV-positive and HIV-negative drug users in South India. (Oral presentation) 18th Annual International AIDS Conference, Vienna, Austria, July 18-23, 2010.
Tang AM, Dong KR, Skinner S, Imai C, Wanke CA. Eating patterns in a cohort of HIV-positive and HIV-negative current and former drug users living in three US cities. 41st American Society of Addiction Medicine Conference. April 16, 2010, San Francisco, CA.
Barbara R, Wanke C, Nguyen H, Trinh L, et al. Characterization of HIV-1 CRF01_AE integrase gene in a cohort of Vietnamese drug users. 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. 2009
Blackard JT, Ma G, Dryer PD, Limketkai BN, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ. Hepatitis C virus (HCV) variability in NS5B and HVR1 among high-risk women. (Poster Presentation P-18) 5th International Workshop on HIV & Hepatitis Co infection, Lisbon, Portugal, June 4-6 2009.
Forrester JE, Wang, XD, Knox TA, Tang AM, Johnson EJ. Factors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis and drug use. J Public Health Policy, 2009; 30(3): 285-99. PMCID#: 140612
Hendricks KM, Gorbach SL. Nutrition Issues in Chronic Drug Users Living with HIV Infection. Addict Sci Clin Pract 2009 April. 5(1):16-23.
Hendricks KM, Erzen HD, Wanke CA, Tang AM. Nutrition issues in the HIV Infected Injection Drug User: Findings from the Nutrition for Healthy Living Cohort. J Am Coll Nutr (in press).
Holubar M, Taylor LE, Wu K, Bosch RJ, Mayer KH, Tahsima KT: HCV antibody seroconversion in a U.S. Hiv-infected male clinical traials population. 60th Annual Meeting of the AASLD, November 2009, Boston, MA.
Jordan M, Wanke C, La H, Sheehan H, et al. Correlates of HIV-1 viral suppression in a 12-month follow-up study of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam. 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. 2009.
Jordan MR, La H, Nguyen HD, Sheehan H, Lien TTM, Dang DV, Hellinger J, Wanke C, Tang AM. Correlates of viral suppression in a cohort of HIV-positive injection drug users in Hanoi, Vietnam. Int J STD & AIDS 2009; 20:418–422.
Sheehan HB, Benetucci J, Muzzio E, et al. Serum micronutrient status of HIV-positive and HIV-negative drug users in Buenos Aires, Argentina. 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. 2009.
Sulkowski MS, Limketkai B, Mehta SH, et al. Incidence of end-stage liver disease and death among 585 HIV/HCV coinfected adults according to baseline fibrosis stage. 60th Annual Meeting of the AASLD, November 2009, Boston, MA., Abstract 1617
Tang AM, Ramachandran R, Nguyen H, et al. Nutritional status in HIV-infected drug users in Hanoi, Vietnam and Chennai, South India. 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. 2009.
Taylor LE, DeLong AK, Gholam PM, Mayer KH, Rodriguez Perez I, Shah R, Chapman S, Ducharme RB, Wohlschlegel W, Chapin KC, Rich JD. Screening for Acute Hepatitis C Virus Infection among At-Risk Patients in an HIV Clinic. (Oral Presentation 173) 13th International Symposium on Viral Hepatitis and Liver Disease, Washington, DC, March 20-24, 2009.
Woods MN, Wanke CA, Ling P-R, Hendricks KM, Tang AM, Andersson CE, Dong KR, Sheehan HMB, and Bistrian BR. Metabolic syndrome and serum fatty acid patterns in serumphospholipids in hypertriglyceridemic persons with human immunodeficiency virus. 2009; 89(4):1180-7.
Woods MN, Wanke CA, Ling P-R, Hendricks KM, Tang AM, Knox TA, Andersson CE, Dong KR, Skinner S, and Bistrian BR. Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV. 2009; 90:1566-78. PMID: 19846544
Castaneda-Sceppa C, Bermudez OI, Wanke CA, Forrester JE. Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the HIV and Hepatitis C Virus. J Viral Hep 2008; 15(12):878-887.
Fishbein DH. Todd AC. Ricketts EP. Semba RD. Relationship between lead exposure, cognitive function, and drug addiction: pilot study and research agenda. Environmental Research. 2008 Nov;108(3):315-9.
Forrester JE, Tucker KL, Skinner S, Terrin N. Drug use and weight loss in HIV-infected Hispanic men. AIDS Care. 2008 Aug;20(7):868-75.
Forrester J, Sheehan H, Joffe T. A validation study of body composition by Bioelectrical Impedance Analysis in HIV-Positive and HIV-Negative Hispanic men and women. JADA, 108:534-8, 2008 March.
Hammer J, Kosmiski L, Bush T, Conley L, Lichtenstein K, Overton T, Taylor L, Wood K, Henry K, Brooks J. Clinical Assessment predicts radiographic measures of lipoatrophy and lipohypertrophy in men and women living with HIV infection in the SUN study. (Poster Presentation THPE0165) AIDS 2008: XVII International AIDS Conference, Mexico City, Mexico, August 3-8, 2008.
Knox TA, Oleson L, von Moltke LL, Kaufman RC, Wanke CA, Greenblatt DJ. Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis. JAIDS. 2008 Dec;49(4):358-68.
La, H., Flanigan, T., Skinner, S., and Tang, A. Polysubstance use and adherence to antiretroviral therapy among HIV-positive drug users in Hanoi, Vietnam. 3rd International Conference on HIV Treatment Adherence, Jersey City, NJ, Abstract March 2008.
La, H., Sheehan, H., Nguyen, H., Trinh, L., Dang, D., and Tang, A. Validity of visual analog scale and correlates of self-reported adherence to antiretroviral therapy among HIV-positive drug users in Hanoi, Vietnam. 3rd International Conference on HIV Treatment Adherence, Jersey City, NJ, Abstract March 2008.
Mitty JA, Bazerman LB, Selwyn K, Beckwith CG, Zaller ND, Rich JD. Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island. AIDS Read. 2008 Dec;18(12):596-600.
Quach LA, Wanke CA, Schmid CH, Gorbach SL, Mwamburi DM, Mayr KH, Spiegelman D, Tang AM. Drug use and other risk factors related to lower body mass index among HIV-infected individuals. Drug and Alcohol Dependence, 95:30-36, 2008.
Rhee MS, Schmid CH, Stevens LA, Forrester JE. Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug users. Am J Kidney Dis. 2008 Oct;52(4):683-90.
Smit E. and Tang AM. Injection Drug Users. In: Nutrition Management of HIV and AIDS. American Dietetic Association, 2008.
Tate D, Conley J, Paul R, Coop K, Bolden K, Laidlaw D, Zhang S, Taylor L, Flanigan T, Tashima K. Hepatitis C Virus Co-Infection Does Not Significantly Worsen Neuroimaging Measures of Diffusivity in HIV Infected Patients. (Poster Presentation 415) 15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 3-6, 2008.
Taylor L, Gholam P, Delong A, Rompalo A, Klein R, Schuman P, Gardner L, Carpenter C, HIV Epidemiology Research (HER) Study Group. Occult hepatitis B virus (HBV) and hepatitis C virus (HCV) viremia in women with and at-risk for HIV/AIDS. (Oral Presentation in Abstract Driven Session THAB0204) AIDS 2008: XVII International AIDS Conference, Mexico City, Mexico, August 3-8, 2008.
Golub ET, Ghanem K, Dobs AS, Wand G, Kirk GD, Mehta SH, Cofrancesco Jr, J. The Effects of HIV Infection and Decreased Frequency of Injection Drug Use on Gonadal Hormone Levels in U.S. Men. Submitted to International AIDS Conference, August 2006, Toronto, Canada.
La, H., Tang, A., Nguyen, H., Trinh, L., Dang, D., Hellinger, J., Quack, L., Sheehan, H., and Jordan, M. Correlation of visual analog scale and 2-week self report of ART adherence among drug users in Hanoi, Vietnam. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia Abstract #CDB341, 2007.
Rhee M, Schmid C, Stevens L, Tang AM, Forrester J. Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug abusers. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention incorporating the 19th ASHM Conference. July 22-25, 2007, Sydney, Australia. Abstract #MOPEB071.
Tang AM, Muzzio E, Naveira J, Segura M, Sheehan H, Benetucci J, Redini L, Weissenbacher M, Hellinger J. Factors associated with depressive symptoms among HIV-positive and HIV-negative drug users in Buenos Aires, Argentina. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention incorporating the 19th ASHM Conference. July 22-25, 2007, Sydney, Australia. Abstract #CDB454.
Floris-Moore M, Howard AA, Lo Y, Arnsten JH, Santoro N, Schoenbaum EE. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med. 2006 Oct;7(7):421-30.
Jones, CY, Tang AM, Forrester JE, Huang J, Hendricks KM, Knox TA, Spiegelman D, Semba RD, Woods MN. Micronutrient Levels and HIV Disease Status in HIV-Infected Patients on Highly Active Antiretroviral Therapy in the Nutrition for Healthy Living Cohort. JAcquir Immune Defic Syndr. 2006; 43(4):475-482.
Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. [Review] Clin Infect Dis. 2006 Mar;42(6):836-42.
McGovern BH, Ditelberg JS, Taylor LE, Grandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis. 2006 Aug 1;43(3):365-72.
Mitty JA. Bazerman LB. Loewenthal HG. Zuba SL. Morrow K. The Preference for Near-Peer Outreach Workers in a Combined Adherence/Secondary Prevention Intervention for Individuals Being Released from Correctional Facilities. Poster presentation at the NIMH/IAPAC International Conference on HIV Treatment Adherence. 2006; Jersey City.
Mitty JA, Mwamburi DM, Macalino GE, Caliendo A, Bazerman LB, Flanigan TP. Improved Virologic Outcomes and Less HIV Resistance for HAART-Experienced Substance Users Receiving Modified Directly Observed Therapy (MDOT): Results from a Randomized Controlled Trial. Poster presentation at the 13th Conference on Retroviruses and Opportunistic Infections. 2006; Denver.
Jordan MR, Kearney M, Palmer S, Goh W-C, Bau V, Stone D, Wanke C, Coakley E, Chappey C, Coffin J. Diversity and Divergence: An Analysis of HIV-1 pol Sequences Derived from Cloning and from Single Genome Sequencing. HIV Dynamics and Evolution April 2006, Poster.
Jordan MR , Kearney M, Palmer S, Goh W-C, Bau V, Coakley EP, Chappey C, Coffin J. Prevalence of HIV Antiretroviral Drug Resistance Mutations in Drug Naïve Subjects with an Analysis of pol Gene Sequences Derived from Cloning and from Single Genome Sequencing. 11th International Workshop on Virus Evolution and Molecular Epidemiology, Petropolis Brazil 2005, Abstract #11.
McGovern B, Ditelberg J, Taylor L, et al. Hepatic steatosis is associated with dideoxynucleoside analogues and HCV genotype 3 in HIV-HCV co-infected patients [Abstract]. Presented at the 12 th Conference on Retroviruses and Opportunistic Infections, February 2005, Boston, Massachusetts.
Mitty JA, Hogan JW, Macalino GE, DeLong AK, Bazerman LB, Loewenthal HG, Flanigan TP. A Randomized Controlled Trial of Modified Directly Observed HAART (MDOT) vs. Standard of Care (SOC) Among HIV+ Active Substance Users. Poster presentation at the Infectious Disease Society of America 43nd Annual Meeting. 2005; San Francisco.
Mitty JA, Macalino GE, Bazerman LB, Loewenthal HG, Hogan JW, MacLeod CJ, Flanigan TP. The use of community-based modified directly observed therapy for the treatment of HIV-infected persons, J Acquir Immune Defic Syndr, 2005; 39(5):545-50.
Jordan MR, Goh W-C, Bau V, Chappey C, Wanke C, Coakley EP. Study to Define the Prevalence of HIV-1 Drug Resistance and Co-Infection in Antiretroviral Naïve Tufts-New England Medical Center Infectious Disease Clinic Patients and in Antiretroviral Naïve Incarcerated Individuals in the State of Massachusetts., Fifth HIV DRP Symposium: Antiviral Drug Resistance 2004, Poster 50.